KRAS and neoplasm: Forty patients (37.7%) had a detectable KRAS mutation (mutKRAS) in codon G12V, G12D or G13D, and four patients (3.7%) had less common mutKRAS on tumour tissue (i.e., G12A = 2; A146T = 1; G12R = 1).